Ventyx Biosciences, Inc.
VTYX
$7.94
-$1.44-15.35%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 192.64M | 208.96M | 228.81M | 217.32M | 274.83M |
| Total Receivables | 500.00K | 1.00M | 500.00K | 1.00M | 400.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 7.96M | 9.36M | 13.25M | 11.30M | 14.18M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 201.09M | 219.32M | 242.56M | 229.63M | 289.41M |
|
|
|||||
| Total Current Assets | 201.09M | 219.32M | 242.56M | 229.63M | 289.41M |
| Net Property, Plant & Equipment | 9.38M | 9.70M | 9.94M | 10.28M | 10.62M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 987.00K | 987.00K | 987.00K | 1.03M | 1.07M |
| Total Assets | 211.47M | 230.01M | 253.48M | 276.56M | 301.10M |
|
|
|||||
| Total Accounts Payable | 993.00K | 913.00K | 2.32M | 3.13M | 2.29M |
| Total Accrued Expenses | 9.08M | 9.42M | 8.98M | 8.59M | 9.01M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.18M | 1.14M | 1.09M | 1.05M | 1.01M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 11.26M | 11.47M | 12.39M | 12.78M | 12.30M |
|
|
|||||
| Total Current Liabilities | 11.26M | 11.47M | 12.39M | 12.78M | 12.30M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 8.84M | 9.16M | 9.45M | 9.74M | 10.03M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 20.10M | 20.63M | 21.85M | 22.52M | 22.33M |
|
|
|||||
| Common Stock & APIC | 822.71M | 817.87M | 813.23M | 808.20M | 802.86M |
| Retained Earnings | -631.57M | -608.74M | -581.75M | -554.31M | -524.96M |
| Treasury Stock & Other | 223.00K | 248.00K | 154.00K | 157.00K | 873.00K |
| Total Common Equity | 191.36M | 209.38M | 231.63M | 254.05M | 278.77M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 191.36M | 209.38M | 231.63M | 254.05M | 278.77M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 191.36M | 209.38M | 231.63M | 254.05M | 278.77M |
|
|
|||||